Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00458783 · ClinicalTrials.gov registry record · NA
Red Cell Storage Duration and Outcomes in Cardiac Surgery
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 3,942
- Enrollment target
NCT00458783: Completed NA study, sponsored by The Cleveland Clinic.
NCT00458783 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 3,942 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (181% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00458783, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,942 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether length of storage of RBC is related to postoperative morbid outcomes in patients undergoing cardiac surgery.
Primary Outcome
The primary composite endpoint was the occurrence of mortality or multisystem organ failure, cardiac events (ventricular tachycardia, fibrillation, or asystole; atrial fibrillation), pulmonary events (pneumonia, prolonged postoperative ventilation, pulmonary embolus), neurologic events (stroke, coma), renal failure, infection (deep sternal wound infection, sepsis), gastrointestinal events (ischemia, infarction), any reoperation (for bleeding, tamponade, cardiac dysfunction), and vascular events
Interventions
- BIOLOGICAL Prolonged RBC storage
- BIOLOGICAL Short RBC storage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,942 participants |
| Start Date | 2007-04 |
| Est. Completion | 2019-01-16 |
| Phase | NA |
What the finished NCT00458783 record still lists
NCT00458783 is an interventional study that assigns participants to a tested intervention. Its 3,942 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (181% higher).
The record links to 0 conditions, and to 2 interventions - of which Prolonged RBC storage is the first listed.
NCT00458783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00458783 about?
NCT00458783 is a clinical study titled "Red Cell Storage Duration and Outcomes in Cardiac Surgery". The purpose of this study is to determine whether length of storage of RBC is related to postoperative morbid outcomes in patients undergoing cardiac surgery.
What is the current status of trial NCT00458783?
This trial is currently completed. It is a NA study. The enrollment target is 3,942 participants. The study started on 2007-04. Estimated completion is 2019-01-16.
What interventions are being tested in trial NCT00458783?
The interventions under investigation include: Prolonged RBC storage (BIOLOGICAL), Short RBC storage (BIOLOGICAL).
Who is sponsoring clinical trial NCT00458783?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00458783's enrollment target sits among peer trials
3,942 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936335 · 3,930 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
- NCT05879926 · 3,960 participants · Phase 3
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- NCT05919342 · 3,904 participants · NA
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia